Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine to Treat COVID in India Jun 8, 2021
National Institutes of Health Director Praises Psychedelics and Medical Cannabis Research May 31, 2021
PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease May 25, 2021
Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip May 17, 2021
